|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01696 SISRAM MED
Nominal 
3.580 -0.040 (-1.105%) | 2024/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2023/06 USD(K$) | 2022/06 USD(K$) | 2021/06 USD(K$) | 2020/06 USD(K$) | |
| Turnover | 168,730 | -1.685% | 171,621 | 174,504 | 125,293 | 71,736 |
| Cost of Sales | (63,419) | -4.379% | (66,323) | (74,890) | (53,815) | (31,834) |
| Gross Profit | 105,311 | 0.012% | 105,298 | 99,614 | 71,478 | 39,902 |
| 2024/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2023/06 USD(K$) | 2022/06 USD(K$) | 2021/06 USD(K$) | 2020/06 USD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (1) | -99.517% | (207) | (74) | (270) | 0 | |
| Profit / (Loss) before Taxation | 14,723 | -28.984% | 20,732 | 23,072 | 20,137 | 6,394 | |
| Taxation | (1,521) | -21.960% | (1,949) | (2,545) | (2,776) | (656) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (2,250) | -- | 116 | 94 | (982) | (234) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 10,952 | -42.050% | 18,899 | 20,621 | 16,379 | 5,504 | |
| 2024/06 - Interim USD(K$) | %Chg (Compare to Interim) | 2023/06 USD(K$) | 2022/06 USD(K$) | 2021/06 USD(K$) | 2020/06 USD(K$) | |
| Net Finance Costs / (Income) | 738 | 15.856% | 637 | 1,029 | 921 | 348 |
| Depreciation & Amortisation | 8,554 | 44.371% | 5,925 | 6,177 | 6,622 | 5,125 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | 2.340 | -42.079% | 4.040 | 4.420 | 3.700 | 1.240 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 0.967 | -- | 0.942 | 0.878 | 0.778 | 0.736 |
| Remarks: | Real time quote last updated: 23/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | USD 10,952,000 |
| %Change | -42.050% |
| EPS / (LPS) | USD 0.023 |
| NBV Per Share ($) | USD 0.967 |